Neil Chatterji
Stock Analyst at B. Riley Securities
(1.09)
# 3,450
Out of 4,829 analysts
17
Total ratings
26.67%
Success rate
-3.74%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $15 → $20 | $14.11 | +41.74% | 2 | Jan 28, 2025 | |
| OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $9.99 | +30.13% | 3 | Dec 24, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $33.92 | +47.41% | 2 | Nov 9, 2023 | |
| ARAY Accuray | Reiterates: Buy | $7.5 | $1.51 | +396.69% | 1 | Oct 4, 2023 | |
| ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $12.05 | +49.38% | 2 | Sep 8, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $3.13 | +43.77% | 1 | Sep 7, 2023 | |
| HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $0.74 | +370.43% | 3 | Aug 15, 2023 | |
| STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $2.13 | +158.22% | 2 | Mar 6, 2023 | |
| BFLY Butterfly Network | Initiates: Buy | $9.5 | $2.23 | +326.01% | 1 | Oct 4, 2022 |
ClearPoint Neuro
Jan 28, 2025
Maintains: Buy
Price Target: $15 → $20
Current: $14.11
Upside: +41.74%
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $9.99
Upside: +30.13%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $33.92
Upside: +47.41%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $1.51
Upside: +396.69%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $12.05
Upside: +49.38%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $3.13
Upside: +43.77%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $0.74
Upside: +370.43%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $2.13
Upside: +158.22%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $2.23
Upside: +326.01%